Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in Macrophages
Open accessAbstract
Endoplasmic reticulum (ER) stress promotes tumor cell escape from immunosurveillance. However, the underlying mechanisms remain unknown. We hypothesized that ER stress induces hepatocellular carcinoma (HCC) cells to release exosomes, which attenuate antitumor immunity by modulating the expression of programmed death ligand 1 (PD‐L1) in macrophages. In this study, we demonstrated that expression of several ER stress markers (glucose‐regulated protein 78, activating transcription factor 6, protein kinase R–like ER kinase, and inositol‐requiring enzyme 1α) was up‐regulated in HCC tissues and negatively correlated with the overall survival and clinicopathological scores in patients with HCC. Expression of ER stress–related proteins positively correlated with CD68 + macrophage recruitment and PD‐L1 expression in HCC tissues. High‐throughput sequencing analysis identified miR‐23a‐3p as one of the most abundant microRNAs in exosomes derived from tunicamycin (TM)‐treated HCC cells (Exo‐TMs). miR‐23a‐3p levels in HCC tissues negatively correlated with overall survival. Treatment with Exo‐TMs up‐regulated the expression of PD‐L1 in macrophages in vitro and in vivo . Bioinformatics analysis suggests that miR‐23a‐3p regulates PD‐L1 expression through the phosphatase and tensin homolog (PTEN)–phosphatidylinositol 3‐kinase–protein kinase B (AKT) pathway. This notion was confirmed by in vitro transfection and coculture experiments, which revealed that miR‐23a‐3p inhibited PTEN expression and subsequently elevated phosphorylated AKT and PD‐L1 expression in macrophages. Finally, coculture of T cells with Exo‐TM–stimulated macrophages decreased CD8 + T‐cell ratio and interleukin‐2 production but increased T‐cell apoptosis in vitro . Conclusion : ER‐stressed HCC cells release exosomes to up‐regulate PD‐L1 expression in macrophages, which subsequently inhibits T‐cell function through an exosome miR‐23a–PTEN–AKT pathway. Our findings provide insight into the mechanism how tumor cells escape from antitumor immunity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Abundant miR-23a-3p in exosomes of tetracycline-treated HCC cells inhibits PTEN mRNA level.
“Abundant expression of miR-23a-3p was found in the exosomes of HCC cells treated with tetracycline, resulting in inhibition of PTEN mRNA level.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
The Abstract identifies the treatment as tunicamycin, not tetracycline. The Results report elevated miR-23a-3p in exosomes from those HCC cells and show that the exosomes reduced PTEN mRNA in co-cultured macrophages (Fig. 8A–C); the treatment named in the claim is therefore unsupported. (LLM, conf=0.90)
Experimental — accuracy not yet measuredExosomes can effectively transmit the regulatory effects of miR-23.
“The exosomes can effectively transmit the regulatory effects of miR-23 as a channel.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
miR-23a-3p enhances phosphorylated AKT and PD-L1 in macrophages and inhibits T cell function via the miR-23a-PTEN-AKT pathway.
“Subsequently, it enhances the expression of phosphorylated AKT and PD-L1 in macrophages and inhibits T cell function by functioning on the miR-23a-PTEN-AKT pathway [77].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · see citing works
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231 · see citing works
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,208 · see citing works
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works
Llovet, J. M., Burroughs, A. K., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,613 · see citing works
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,382 · see citing works
From endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010 · see citing works
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,561 · see citing works
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · see citing works
PD-L1 Expression in Triple-Negative Breast Cancer
Mittendorf, E. A., Philips, A. V., Meric‐Bernstam, F., Qiao, N., Wu, Y., Harrington, S. M., Su, X., Wang, Y., Gonzalez-Angulo, A. M., Akçakanat, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0127 · Cited by 1,394 · see citing works
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,341 · see citing works
Kuang, D., Zhao, Q., Peng, C., Xu, J., Zhang, J., Wu, C. Y., & Zheng, L. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 897 · see citing works
Self-citationFu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897 · see citing works
Self-citationTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
Cubillos‐Ruiz, J. R., Bettigole, S. E., & Glimcher, L. H. (2017) · Cell · doi:10.1016/j.cell.2016.12.004 · Cited by 892 · see citing works
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L., Tang, Z., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 843 · see citing works
The unfolded protein response in immunity and inflammation
Grootjans, J., Kaser, A., Kaufman, R., & Blumberg, R. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.62 · Cited by 766 · see citing works
Goswami, S. K., Sahai, E. A., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., & Condeelis, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1853 · Cited by 739 · see citing works
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 676 · see citing works
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
Lipson, E. J., & Drake, C. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1595 · Cited by 569 · see citing works
Kogure, T., Lin, W.-L., Yan, I. K., Braconi, C., & Patel, T. (2011) · Hepatology · doi:10.1002/hep.24504 · Cited by 551 · see citing works
Intercellular Communication by Exosome-Derived microRNAs in Cancer
Hannafon, B. N., & Ding, W. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714240 · Cited by 518 · see citing works
Endoplasmic Reticulum Stress in Malignancy
Clarke, H. J., Chambers, J. E., Liniker, E., & Marciniak, S. J. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.015 · Cited by 461 · see citing works
Yeung, O. W. H., Lo, C. M., Ling, C.-C., Qi, X., Geng, W., Li, C. X., Ng, K. T., Forbes, S. J., Guan, X., Poon, R. T. P., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.029 · Cited by 453 · see citing works
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380 · see citing works
Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells
Mahadevan, N. R., Rodvold, J. J., Sepulveda, H., Rossi, S. S., Drew, A. F., & Zanetti, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008942108 · Cited by 294 · see citing works
Matsuzaki, K., Murata, M., Yoshida, K., Sekimoto, G., Uemura, Y., Sakaida, N., Kaibori, M., Kamiyama, Y., Nishizawa, M., Fujisawa, J., et al. (2007) · Hepatology · doi:10.1002/hep.21672 · Cited by 291 · see citing works
Arihara, F., Mizukoshi, E., Kitahara, M., Takata, Y., Arai, K., Yamashita, T., Nakamoto, Y., & Kaneko, S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1447-1 · Cited by 254 · see citing works
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
Shlomai, A., de Jong, Y. P., & Rice, C. M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.004 · Cited by 177 · see citing works
Zhu, J., Chen, L., Zou, L., Yang, P., Wu, R., Mao, Y., Zhou, H., Li, R., Wang, K., Wang, W., et al. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.01.006 · Cited by 169 · see citing works
Gurzov, E. N., Ortis, F., Cunha, D. A., Gosset, G., Li, M., Cardozo, A. K., & Eizirik, D. L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.99 · Cited by 161 · see citing works
Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress
Kanemoto, S., Nitani, R., Murakami, T., Kaneko, M., Asada, R., Matsuhisa, K., Saito, A., & Imaizumi, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.019 · Cited by 158 · see citing works
Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment
Penfornis, P., Vallabhaneni, K. C., Whitt, J. D., & Pochampally, R. R. (2015) · International Journal of Cancer · doi:10.1002/ijc.29417 · Cited by 152 · see citing works
Tan, X., Wang, S., Zhu, L., Wu, C., Yin, B., Zhao, J., Yuan, J., Qiang, B., & Peng, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207787109 · Cited by 117 · see citing works
MicroRNA-23a promotes myelination in the central nervous system
Lin, S.-T., Huang, Y., Zhang, L., Heng, M. Y., Ptáček, L. J., & Fu, Y.-H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317182110 · Cited by 117 · see citing works
Lee, B., Chang, S.-Y., Hong, E.-H., Kwon, B.-E., Kim, H. M., Kim, Y., Lee, J., Cho, H., Cheon, J. H., & Ko, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2589 · Cited by 96 · see citing works
Cho, Y., Mezey, E., Hardwick, J. P., Salem, N., Clemens, D. L., & Song, B. (2017) · Hepatology Communications · doi:10.1002/hep4.1066 · Cited by 96 · see citing works
Zhang, H. H., Mei, M.-H., Fei, R., Liu, F., Wang, J. H., Liao, W., Qin, L. L., Wei, L., & Chen, H. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01269.x · Cited by 87 · see citing works
Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress–induced apoptosis
Zha, L., Fan, L., Sun, G., Wang, H., Ma, T., Zhong, F., & Wei, W. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00946.x · Cited by 74 · see citing works
Self-citationFan, L., Sun, G., Ma, T., Zhong, F., Yu, L., Li, X., & Wei, W. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12061 · Cited by 71 · see citing works
Self-citationRachidi, S., Sun, S., Wu, B. X., Jones, E. E., Drake, R. R., Öğretmen, B., Cowart, L. A., Clarke, C. J., Hannun, Y. A., Chiosis, G., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.010 · Cited by 65 · see citing works
Chang, L.-Y., Lin, Y., Chiang, J., Mahalingam, J., Su, S.-H., Huang, C., Chen, W., Huang, C., Jeng, W., Chen, Y., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1040215 · Cited by 55 · see citing works
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model
Li, G., Liu, D., Cooper, T. K., Kimchi, E. T., Qi, X., Avella, D. M., Li, N., Yang, Q. X., KESTER, M. A., Rountree, C. B., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.044 · Cited by 51 · see citing works
Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFNβ
Staples, K. J., Nicholas, B., McKendry, R., Spalluto, C. M., Wallington, J. C., Bragg, C. W., Robinson, E. C., Martin, K., Djukanović, R., & Wilkinson, T. M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121527 · Cited by 50 · see citing works
Management strategies for hepatocellular carcinoma: old certainties and new realities
Mazzoccoli, G., Tarquini, R., Valoriani, A., Oben, J. A., Vinciguerra, M., & Marra, F. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0368-z · Cited by 30 · see citing works
Lanton, T., Shriki, A., Nechemia‐Arbely, Y., Abramovitch, R., Levkovitch‐Siany, O., Adar, R., Rosenberg, N., Paldor, M., Goldenberg, D., Sonnenblick, A., et al. (2016) · Hepatology · doi:10.1002/hep.29004 · Cited by 28 · see citing works
Cell‐extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells
Zanetti, M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12103 · Cited by 23 · see citing works
PD-L1 in non-small-cell lung cancer: the third target for immunotherapy
Smit, E. F., & van den Heuvel, M. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00700-5 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356 · see citing works
Regulatory mechanisms of PD-1/PD-L1 in cancers
Lin, X., Kang, K., Chen, P., Zeng, Z., Li, G., Xiong, W., Yi, M., & Xiang, B. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02023-w · Cited by 850 · see citing works
Regulation of PD-L1 expression in the tumor microenvironment
Yi, M., Niu, M., Xu, L., Luo, S., & Wu, K. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01027-5 · Cited by 681 · see citing works
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Zhang, H., Dai, Z., Wu, W., Wang, Z., Zhang, N., Zhang, L., Zeng, W., Liu, Z., & Cheng, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01987-7 · Cited by 543 · see citing works
Isolation and characterization of exosomes for cancer research
Zhu, L., Sun, H., Wang, S., Huang, S., Zheng, Y., Wang, C., Hu, B., Qin, W., Zou, T., Fu, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00987-y · Cited by 529 · see citing works
The significance of exosomes in the development and treatment of hepatocellular carcinoma
Li, X., Li, C., Zhang, L., Wu, M. Y., Cao, K., Jiang, F., Chen, D., Li, N., & Li, W. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1085-0 · Cited by 503 · see citing works
Self-citationMicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Wang, X., He, Y., Mackowiak, B., & Gao, B. (2020) · Gut · doi:10.1136/gutjnl-2020-322526 · Cited by 491 · see citing works
Self-citationEndoplasmic reticulum stress in liver diseases
Ajoolabady, A., Kaplowitz, N., Lebeaupin, C., Kroemer, G., Kaufman, R. J., Malhi, H., & Ren, J. T. (2022) · Hepatology · doi:10.1002/hep.32562 · Cited by 410 · see citing works
The role of exosomal PD-L1 in tumor progression and immunotherapy
Xie, F., Xu, M., Lu, J., Mao, L., & Wang, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1074-3 · Cited by 354 · see citing works
Xu, Z., Chen, Y., Ma, L., Chen, Y., Liu, J., Guo, Y., Yu, T., Zhang, L., Zhu, L., & Shu, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.046 · Cited by 325 · see citing works
Self-citationEndoplasmic reticulum stress-mediated cell death in liver injury
Zhang, J., Guo, J., Yang, N., Huang, Y., Hu, T., & Rao, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05444-x · Cited by 284 · see citing works
Self-citationYin, Y., Liu, B., Cao, Y., Yao, S., Liu, Y., Jin, G., Yan, Q., Chen, Y., Cui, K., Zhou, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202102620 · Cited by 245 · see citing works
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Chu, X., Tian, Y., & Lv, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02064-1 · Cited by 231 · see citing works
Hu, W., Liu, C., Bi, Z., Zhou, Q. Y., Zhang, H., Li, L., Zhang, J., Zhu, W., Song, Y., Zhang, F., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01199-1 · Cited by 216 · see citing works
Self-citationByun, J., Park, M., Lee, S., Yun, J. W., Lee, J., Kim, J. S., Cho, S. J., Jeon, H.-J., Lee, I., Choi, Y., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.015 · Cited by 208 · see citing works
Nail, H. M., Chiu, C., Leung, C., Ahmed, M. M. M., & Wang, H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00964-w · Cited by 198 · see citing works
Self-citationImmune checkpoint inhibitor resistance in hepatocellular carcinoma
Wang, Z., Wang, Y., Gao, P., & Ding, J. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216038 · Cited by 190 · see citing works
Yao, X., Tu, Y., Xu, Y., Guo, Y., Yao, F., & Zhang, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15367 · Cited by 185 · see citing works
Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy
Morrissey, S. M., & Yan, J. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.03.002 · Cited by 173 · see citing works
Yang, Z., Huo, Y., Zhou, S., Guo, J., Ma, X., Li, T., Fan, C., & Wang, L. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.010 · Cited by 174 · see citing works
Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology
Yokoi, A., & Ochiya, T. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.032 · Cited by 169 · see citing works
Zhou, C., Wei, W.-F., Ma, J., Yang, Y., Liang, L.-J., Zhang, Y., Wang, Z., Chen, X., Huang, L., Wang, W., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.034 · Cited by 154 · see citing works
Self-citationYou, Y., Wen, D., Zeng, L., Lu, J., Xiao, X., Chen, Y., Song, H., & Liu, Z. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70149 · Cited by 135 · see citing works
Hepatic Macrophages in Liver Injury
Shan, Z., & Ju, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00322 · Cited by 132 · see citing works
Extracellular vesicles remodel tumor environment for cancer immunotherapy
Yue, M., Hu, S., Sun, H., Tuo, B., Jia, B., Chen, C., Wang, W., Liu, J., Liu, Y., Sun, Z., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01898-5 · Cited by 123 · see citing works
Self-citationHCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
Han, Q., Zhao, H., Yu, J., Yin, C., & Zhang, J. (2019) · Cells · doi:10.3390/cells8060558 · Cited by 119 · see citing works
Self-citationThe cancer exosomes: Clinical implications, applications and challenges
Tang, Z., Li, D., Hou, S., & Zhu, X. M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32762 · Cited by 115 · see citing works
Yin, Y., Feng, W., Chen, J., Chen, X., Wang, G., Wang, S., Xu, X., Nie, Y., Fan, D., Wu, K., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00539-x · Cited by 118 · see citing works
Chen, H., Zhang, C., Wang, H., & Zhao, L. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1887552 · Cited by 111 · see citing works
Self-citationMao, X., Tey, S. K., Yeung, C. L. S., Kwong, E. M. L., Fung, Y. M. E., Chung, C. Y., Mak, L., Wong, D. K.-H., Yuen, M., Ho, J., et al. (2020) · Advanced Science · doi:10.1002/advs.202002157 · Cited by 103 · see citing works
Li, X., Wang, S., Mu, W., Barry, J., Han, A., Carpenter, R. L., Jiang, B., Peiper, S. C., Mahoney, M. G., Aplin, A. E., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02244-1 · Cited by 103 · see citing works
Self-citationYugawa, K., Yoshizumi, T., Mano, Y., Itoh, S., Harada, N., Ikegami, T., Kohashi, K., Oda, Y., & Mori, M. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.08.002 · Cited by 102 · see citing works
Touchaei, A. Z., & Vahidi, S. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03293-6 · Cited by 102 · see citing works
Kuzu, O. F., Granerud, L. J. T., & Saatcioglu, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02439-w · Cited by 116 · see citing works
Role of extracellular vesicles in liver diseases and their therapeutic potential
Kostallari, E., Valainathan, S. R., Biquard, L., Shah, V. H., & Rautou, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.026 · Cited by 92 · see citing works
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Yang, M., Cui, M., Sun, Y., Liu, S., & Jiang, W. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01711-w · Cited by 95 · see citing works
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
Martino, M. T. D., Riillo, C., Scionti, F., Grillone, K., Polerà, N., Caracciolo, D., Arbitrio, M., Tagliaferri, P., & Tassone, P. (2021) · Cancers · doi:10.3390/cancers13071587 · Cited by 92 · see citing works
ER membrane contact sites support endosomal small GTPase conversion for exosome secretion
Verweij, F. J., Bebelman, M. P., George, A. E., Couty, M., Bécot, A., Palmulli, R., Heiligenstein, X., Sirés-Campos, J., Raposo, G., Pegtel, D. M., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202112032 · Cited by 91 · see citing works
Liu, M., Wei, F., Wang, J., Yu, W., Shen, M., Liu, T., Zhang, D., Wang, Y., Ren, X., & Sun, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03745-1 · Cited by 85 · see citing works
Zhong, W., Lu, Y., Han, X., Yang, J., Qin, Z., Zhang, W., Yu, Z., Wu, B., Liu, S., Xu, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113224 · Cited by 84 · see citing works
Pan, Z., Bao, Y., Hu, M., Zhu, Y., Tan, C., Fan, L., Yu, H., Wang, A., Cui, J., & Sun, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01355-8 · Cited by 84 · see citing works
Self-citationMicroRNA in extracellular vesicles regulates inflammation through macrophages under hypoxia
Li, Y., Tan, J., Miao, Y., & Zhang, Q. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00670-2 · Cited by 82 · see citing works
Self-citationGiordano, C., Gelsomino, L., Barone, I., Panza, S., Augimeri, G., Bonofiglio, D., Rovito, D., Naimo, G. D., Leggio, A., Catalano, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071027 · Cited by 79 · see citing works
Epigenetic strategies to boost CAR T cell therapy
Akbari, B., Ghahri-Saremi, N., Soltantoyeh, T., Hadjati, J., Ghassemi, S., & Mirzaei, H. R. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.003 · Cited by 78 · see citing works
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy
Tang, Q., Yang, S., He, G., Zheng, H., Zhang, S., Liu, J., Wei, S., Fan, Q., Peng, X., Li, X., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215823 · Cited by 76 · see citing works
Self-citationExosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages
Chen, Q., Li, Y., Gao, W., Chen, L., Xu, W., & Zhu, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.764222 · Cited by 76 · see citing works
Self-citationLiu, J., Peng, X., Yang, S., Li, X., Huang, M., Wei, S., Zhang, S., He, G., Zheng, H., Fan, Q., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00816-w · Cited by 75 · see citing works
Self-citationTargeting the GRP78 Pathway for Cancer Therapy
Lu, G., Luo, H., & Zhu, X. M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00351 · Cited by 73 · see citing works
Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
Zhou, D., Luan, J., Huang, C., & Li, J. (2020) · Gut and Liver · doi:10.5009/gnl20223 · Cited by 73 · see citing works
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer
Zhao, T., Du, J., & Zeng, H. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01002-0 · Cited by 73 · see citing works
Lu, C., Shi, W., Hu, W., Zhao, Y. W., Zhao, X., Dong, F., Yue, X., Peng, T., & Liu, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106098 · Cited by 73 · see citing works
Xu, S., Hu, H.-T., Li, H. L., & Chang, S. (2019) · Cells · doi:10.3390/cells8101140 · Cited by 72 · see citing works
Reese, M., & Dhayat, S. A. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01149-4 · Cited by 72 · see citing works
Shi, Y., Zhang, J., Mao, Z., Jiang, H., Liu, W., Shi, H., Ji, R., Xu, W., Qian, H., & Zhang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00629 · Cited by 71 · see citing works
Self-citationExosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages
Kwon, Y., Kim, M.-S., Kim, Y., Jung, H. S., & Jeoung, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01167 · Cited by 72 · see citing works
Li, C., & Xu, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03215-0 · Cited by 70 · see citing works
An Endoplasmic Reticulum Stress–MicroRNA‐26a Feedback Circuit in NAFLD
Xu, H., Tian, Y., Tang, D., Zou, S., Liu, G., Song, J., Zhang, G., Du, X., Huang, W., He, B., et al. (2020) · Hepatology · doi:10.1002/hep.31428 · Cited by 70 · see citing works
Yang, W., Yang, S., Zhang, F., Cheng, F., Wang, X., & Rao, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.11 · Cited by 69 · see citing works
Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
Sorop, A., Constantinescu, D., Cojocaru, F., Dinischiotu, A., Cucu, D., & Dima, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094997 · Cited by 69 · see citing works
Intercellular Communication between Hepatic Cells in Liver Diseases
Sato, K., Kennedy, L. L., Liangpunsakul, S., Kusumanchi, P., Yang, Z., Meng, F., Glaser, S. S., Francis, H., & Alpini, G. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092180 · Cited by 68 · see citing works
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 68 · see citing works
Self-citationTsai, H., Wu, Y., Liu, X., Xu, Z., Liu, L., Wang, C., Zhang, H., Huang, Y., Wang, L., Zhang, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202102634 · Cited by 68 · see citing works
Extracellular vesicles and immunogenic stress in cancer
Wu, Q., Zhang, H., Sun, S., Wang, L., & Sun, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04171-z · Cited by 67 · see citing works
Tumor immune escape: extracellular vesicles roles and therapeutics application
Ahmadi, M., Abbasi, R., & Rezaie, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01370-3 · Cited by 67 · see citing works
Noncoding RNAs: the shot callers in tumor immune escape
Liu, L., Wang, Q., Qiu, Z., Kang, Y., Liu, J., Ning, S., Yin, Y., Pang, D., & Xu, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0194-y · Cited by 66 · see citing works
Self-citationHe, J., Zhou, Y. L., & Sun, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01438-0 · Cited by 69 · see citing works
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
El‐Mahdy, H. A., Sallam, A.-A. M., Ismail, A., Elkhawaga, S. Y., Elrebehy, M. A., & Doghish, A. S. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153886 · Cited by 64 · see citing works
Mao, X., Zhou, L., Tey, S. K., Ma, A. P. Y., Yeung, C. L. S., Ng, T. H., Wong, S. W. K., Liu, B. H. M., Fung, Y. M. E., Patz, E. F., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12031 · Cited by 63 · see citing works
Exosome-based nanoparticles and cancer immunotherapy
Ye, J., Li, D., Jie, Y., Luo, H., Zhang, W., & Qiu, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117296 · Cited by 66 · see citing works
Pascut, D., Pratama, M. Y., Võ, N. V. T., Masadah, R., & Tiribelli, C. (2020) · Cancers · doi:10.3390/cancers12040823 · Cited by 62 · see citing works
Li, D., Zhang, T., Guo, Y., Bi, C., Liu, M., & Wang, G. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06888-z · Cited by 63 · see citing works
Roles of Macrophages and Exosomes in Liver Diseases
Shen, M., Shen, Y., Fan, X., Men, R., Ye, T., & Yang, L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.583691 · Cited by 61 · see citing works
The current status and future of PD-L1 in liver cancer
Hao, L.-Y., Li, S.-H., Deng, J.-L., Li, N., Yu, F., Jiang, Z., Zhang, J., Shi, X., & Hu, X.-Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323581 · Cited by 59 · see citing works
Self-citationPathania, A. S., Prathipati, P., & Challagundla, K. B. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188624 · Cited by 62 · see citing works
MicroRNA and ER stress in cancer
Kim, T., & Croce, C. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.025 · Cited by 63 · see citing works
Subcellular Localization of miRNAs and Implications in Cellular Homeostasis
Jie, M., Feng, T., Huang, W. C., Zhang, M., Feng, Y., Jiang, H., & Wen, Z. (2021) · Genes · doi:10.3390/genes12060856 · Cited by 58 · see citing works
Shao, Y., Lan, Y., Chai, X., Gao, S., Zheng, J., Huang, R., Shi, Y., Xiang, Y., Guo, H., Xi, Y., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201982rrr · Cited by 60 · see citing works
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
Raue, R., Frank, A.-C., Syed, S. N., & Brüne, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042210 · Cited by 60 · see citing works
Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy
Li, Q., Cai, S., Li, M., Salma, K. I., Zhou, X., Han, F., Chen, J., & Huyan, T. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s313912 · Cited by 59 · see citing works
Babuta, M., & Szabó, G. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0321-156r · Cited by 58 · see citing works
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Xu, S., Wang, C., Yang, L., Wu, J., Li, M., Xiao, P., Xu, Z., Xu, Y., & Wang, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199631 · Cited by 58 · see citing works
The role of exosomal PD-L1 in tumor immunotherapy
Wang, J., Zeng, H., Zhang, H., & Han, Y. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101047 · Cited by 58 · see citing works
Su, T., Zhang, P., Zhao, F., & Zhang, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631703 · Cited by 54 · see citing works
Dou, X., Yan, H., Chen, Z., Chao, F., & Li, M. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac006 · Cited by 53 · see citing works
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Sung, P. S. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0308 · Cited by 52 · see citing works
Liu, L., Li, S., Qu, Y., Bai, H., Pan, X., Wang, J., Wang, Z., Duan, J., Zhong, J., Wan, R., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101206 · Cited by 52 · see citing works
Self-citationExosomes derived from programmed cell death: mechanism and biological significance
Xiong, M., Chen, Z., Tian, J., Peng, Y., Song, D., Zhang, L., & Jin, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01521-0 · Cited by 53 · see citing works
Skafi, N., Fayyad‐Kazan, M., & Badran, B. M. (2020) · Gene · doi:10.1016/j.gene.2020.144888 · Cited by 52 · see citing works
Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
Ayala‐Mar, S., Donoso‐Quezada, J., & González‐Valdez, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/8839978 · Cited by 50 · see citing works
Fan, K., Spassova, I., Gravemeyer, J., Ritter, C., Horny, K., Lange, A., Gambichler, T., Ødum, N., Schrama, D., Schadendorf, D., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01576-6 · Cited by 51 · see citing works
The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma
Zhang, J., Song, Q., Wu, M., & Zheng, W. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200130103206 · Cited by 50 · see citing works
Self-citationTargeting ER stress in the hepatic tumor microenvironment
Pavlović, N., & Heindryckx, F. (2021) · FEBS Journal · doi:10.1111/febs.16145 · Cited by 50 · see citing works
Li, Y., Sui, S., & Goel, A. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.02.001 · Cited by 50 · see citing works
Self-citationMyeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
Arkhypov, I., Lasser, S., Petrova, V., Weber, R., Groth, C., Utikal, J. S., Altevogt, P., & Umansky, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176319 · Cited by 50 · see citing works
Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential
Elewaily, M. I., & Elsergany, A. R. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03534-5 · Cited by 48 · see citing works
Non-coding RNAs and macrophage interaction in tumor progression
Entezari, M., Sadrkhanloo, M., Rashidi, M., Asnaf, S. E., Taheriazam, A., Hashemi, M., Ashrafizadeh, M., Zarrabi, A., Rabiee, N., Hushmandi, K., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103680 · Cited by 48 · see citing works
Genetically Programmable Vesicles for Enhancing CAR‐T Therapy against Solid Tumors
Li, X., Zhu, T., Wang, R., Chen, J., Tang, L., Huo, W., Huang, X., & Cao, Q. (2023) · Advanced Materials · doi:10.1002/adma.202211138 · Cited by 48 · see citing works
Self-citationOtmani, K., Rouas, R., & Lewalle, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.913951 · Cited by 47 · see citing works
Niu, Z.-S., Wang, W., & Niu, X.-J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i46.6433 · Cited by 47 · see citing works
The roles of exosomal immune checkpoint proteins in tumors
Cheng, X., Li, H., Li, R., Yin, L., Zhang, H., Huang, Z., Cheng, Z., Li, J., Wang, Z.-H., & Peng, H. (2021) · Military Medical Research · doi:10.1186/s40779-021-00350-3 · Cited by 47 · see citing works
- Authors
- Liu, J., Fan, L., Yu, H., Zhang, J., He, Y., Feng, D., Wang, F., Li, X., Liu, Q., Li, Y., Guo, Z., Gao, B., Wei, W., Wang, H., & Sun, G.
- Affiliations
- First Affiliated Hospital of Anhui Medical University (CN)
- National Institutes of Health (US)
- Anhui Medical University (CN)
- Corresponding author
- Wang, Hua
- Sun, Guoping
- ORCID
- Venue
- Hepatology
- Published
- 2019-04-25
- Volume
- 70
- Issue
- 1
- Pages
- 241-258
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC6597282
- OpenAlex
- W2922474621
- Cited by
- 449
- References
- 48
- Citations by year
- 2026: 32 · 2025: 55 · 2024: 71 · 2023: 68 · 2022: 86 · 2021: 69 · 2020: 56 · 2019: 12
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Natural Science Foundation of China (81372577, 81522009, 81770588, 81872047, 81602115, 81572430)
- National Institutes of Health
- Natural Science Foundation of Anhui Province (1608085QH195)
- National Institute on Alcohol Abuse and Alcoholism (ZIAAA000368, AA000369, Z01AA000368, Z01AA000369, AA000368, ZIAAA000369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- endoplasmic reticulum stress, hepatocellular carcinoma, exosomes, miR-23a-3p, PD-L1, tumor-associated macrophages, tumor immunosuppression, PTEN/AKT signaling, CD8+ T cells, tunicamycin, tumor microenvironment
- MeSH terms
- China, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Macrophages, T-Lymphocytes, MicroRNAs, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Exosomes, Endoplasmic Reticulum Stress, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review